- Recent Funding
- Investors
- HM Capital
HM Capital portfolio
HM Capital has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is OncoC4's $50M Series B+ round in October 2025, alongside 3E Bioventures, Kaitai Capital and GBA Fund. That company is in Health and bio.
What HM Capital invests in
- Health and bio · 1 · 100%
How HM Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $50M |
HM Capital portfolio companies
| Company | Round with HM Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $50M | $50M | Oct 2, 2025 Series B+ |
Most frequent co-investors
KKaitai Capital1 shared round · last Oct 2, 2025
33E Bioventures1 shared round · last Oct 2, 2025
- GGBA Fund1 shared round · last Oct 2, 2025
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name HM Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists HM Capital, which is a subset of its real portfolio. API: /api/v1/investors/hm-capital (get a free API key). More: the most active VC firms and new venture capital funds.